Neurocrine Biosciences
NBIX
#1642
Rank
NZ$22.30 B
Marketcap
NZ$222.21
Share price
0.48%
Change (1 day)
36.24%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company